Ming Li

Dr. Ming Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2024 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
JZJing Zhang
Jing Zhang
GWGuolong Wang
Guolong Wang
YSYuxuan Shi
Yuxuan Shi
XLXin Liu
Xin Liu
SLShuang Liu
Shuang Liu
MLMing Li
Ming Li
Background: Diabetic cardiomyopathy (DCM) is a crucial complication of long-term chronic diabetes that can lead to myocardial hypertrophy, myocardial fibrosis, and heart failure. There is increasing evidence that DCM is associated with pyroptosis, a form of inflammation-related programmed cell death. Growth differentiation factor 11 (GDF11) is a member of the transforming growth factor β superfamily, which regulates oxidative stress, inflammation, and cell survival to mitigate myocardial hypertrophy, myocardial infarction, and vascular injury. However, the role of GDF11 in regulating pyroptosis in DCM remains to be elucidated. This research aims to investigate the role of GDF11 in regulating pyroptosis in DCM and the related mechanism. Methods and results: Mice were injected with streptozotocin (STZ) to induce a diabetes model. H9c2 cardiomyocytes were cultured in high glucose (50 mM) to establish an in vitro model of diabetes. C57BL/6J mice were preinjected with adeno-associated virus 9 (AAV9) intravenously via the tail vein to specifically overexpress myocardial GDF11. GDF11 attenuated pyroptosis in H9c2 cardiomyocytes after high-glucose treatment. In diabetic mice, GDF11 alleviated cardiomyocyte pyroptosis, reduced myocardial fibrosis, and improved cardiac function. Mechanistically, GDF11 inhibited pyroptosis by preventing inflammasome activation. GDF11 achieved this by specifically binding to apoptosis-associated speck-like protein containing a CARD (ASC) and preventing the assembly and activation of the inflammasome. Additionally, the expression of GDF11 during pyroptosis was regulated by peroxisome proliferator-activated receptor α (PPARα). Conclusion: These findings demonstrate that GDF11 can treat diabetic cardiomyopathy by alleviating pyroptosis and reveal the role of the PPARα-GDF11-ASC pathway in DCM, providing ideas for new strategies for cardioprotection.

2 January 2026 in Aging Cell
Verified
Journal Article
Open access
SYShuyi Yu
Shuyi Yu
QCQian Cheng
Qian Cheng
QYQian Yu
Qian Yu
ZCZhikang Cui
Zhikang Cui
HCHang Chen
Hang Chen
ZLZhiming Lu
Zhiming Lu
Aging is characterized by systemic inflammation and progressive cognitive decline, yet the molecular pathways linking peripheral aging signals to central nervous system dysfunction remain elusive. Here, we identify plasma extracellular vesicle (EV)‐derived long interspersed nuclear element‐1 (LINE‐1) RNA as a potent systemic aging factor mediating neuroinflammation and cognitive impairment in humans and mice. Plasma EV LINE‐1 RNA levels markedly increase with age and strongly correlate with established brain aging biomarkers, including neurofilament light chain (NFL). Utilizing mouse models, we demonstrate that EVs from aged individuals penetrate the blood–brain barrier, deliver LINE‐1 RNA to microglia, and initiate cGAS‐STING signaling, leading to pronounced neuroinflammation, neuronal damage, and impaired cognition. Pharmacological blockade of LINE‐1 reverse transcription by 3TC or inhibition of STING signaling with H151 significantly ameliorates these age‐associated deficits. Notably, aged peripheral tissues, especially brain and lung, emerge as primary sources of pro‐aging EVs enriched with LINE‐1 RNA, revealing a novel mechanism of inter‐organ communication in aging. Our findings position EV‐derived LINE‐1 RNA and its downstream cGAS‐STING pathway as critical systemic drivers of brain aging, presenting promising therapeutic targets for mitigating cognitive decline and age‐related neurodegenerative diseases.

6 June 2025 in Frontiers in Molecular Neuroscience
Verified
Journal Article
Open access
PDF file
QCQian Cheng
Qian Cheng
SYShuyi Yu
Shuyi Yu
ZCZhikang Cui
Zhikang Cui
HCHang Chen
Hang Chen
JFJing Fan
Jing Fan
ZLZhiming Lu
Zhiming Lu
Aim: This study aimed to identify autophagy-related microRNAs (miRNAs) in plasma exosomes as non-invasive biomarkers for brain aging and explore their potential to improve early detection of age-associated neurodegeneration. With the increasing incidence of neurodegenerative disorders, such as Alzheimer’s disease (AD), frontotemporal dementia (FTD), and Parkinson’s disease (PD), non-invasive diagnostic tools are urgently needed.Methods: Plasma samples were collected from 200 individuals, divided into three groups, including young (20–40 years), middle-aged (41–60 years), and elderly (> 60 years). Exosomes were isolated, followed by small RNA sequencing (sRNA-seq) to identify differentially expressed miRNAs, and differentially expressed miRNAs related to autophagy were validated using quantitative real-time PCR (qRT-PCR). Spearman correlation analysis was performed to assess the relationship between autophagy-related miRNAs and brain aging biomarkers. Receiver operating characteristic (ROC) curve analysis was conducted to evaluate the diagnostic performance.Results: Nine autophagy-related miRNAs were identified and validated as significantly upregulated in plasma exosomal from elderly, including hsa-miR-2110, hsa-miR-18a-3p, hsa-miR-766-3p, hsa-miR-4446-3p, hsa-miR-4667-5p, hsa-miR-4433b-3p, hsa-miR-146a-5p, hsa-miR-423-5p, and novel_260. These miRNAs were validated by qRT-PCR. Correlation analysis showed that several of these miRNAs, such as hsa-miR-2110 and hsa-miR-766-3p, were strongly correlated with NfL (r = 0.68, p = 0.002), Aβ42 (r = 0.62, p = 0.004), and p-Tau181 (r = 0.55, p = 0.008). ROC curve analysis showed that combining these miRNAs with NfL resulted in an area under the curve (AUC) of 0.92, outperforming NfL alone (AUC = 0.85) and miRNAs alone (AUC = 0.84). Further subgroup analysis revealed that multiple miRNAs, such as miR-2110, miR-4446-3p, and novel_260, achieved high AUCs (>0.83) in distinguishing middle-aged adults (41–60 years) from older adults (>60 years), supporting their potential utility for early detection of age-associated neurodegeneration.Conclusion: This study identifies a set of autophagy-related miRNAs as promising biomarkers for brain aging. The combination of these miRNAs with traditional biomarkers offers a non-invasive and highly sensitive method for early detection of brain aging, providing significant potential to enhance diagnostic accuracy in neurodegenerative diseases.

27 January 2026 in Neural Regeneration Research
Verified
Journal Article
Open access
ZCZhikang Cui
Zhikang Cui
GLGuixia Li
Guixia Li
SWShuyong Wei
Shuyong Wei
QCQian Cheng
Qian Cheng
QYQian Yu
Qian Yu
ZLZhiming Lu
Zhiming Lu
Alzheimer’s disease is a common neurodegenerative disease characterized by progressive memory loss, cognitive decline, and behavioral changes. Blood-based biomarkers have recently gained significant attention due to their accessibility and cost-effectiveness. This review highlights the latest progress in multiple key areas of blood-based biomarkers for Alzheimer’s disease. For early diagnosis, blood-based biomarkers such as amyloid-β and phosphorylated tau can identify Alzheimer’s disease even before clinical symptoms emerge. Dynamic changes in blood-based biomarkers, including p-tau217 and neurofilament light chain, reflect disease progression and correlate with cognitive decline, enabling continuous monitoring of Alzheimer’s disease progression. Additionally, blood-based biomarkers such as p-tau181 and glial fibrillary acidic protein aid in differential diagnosis by distinguishing Alzheimer’s disease from other dementias such as frontotemporal dementia. Blood-based biomarkers related to nerve repair have opened up new avenues for tracking nerve regeneration and therapeutic response, especially brain-derived neurotrophic factor. Furthermore, advanced detection technologies such as single-molecule array and immunoprecipitation-mass spectrometry have significantly improved the sensitivity and specificity of blood-based biomarkers, facilitating their clinical translation. In summary, blood-based biomarkers hold strong potential to improve early diagnosis, monitor progression, differential diagnosis, and evaluate therapies in Alzheimer’s disease. This review provides a comprehensive and updated evaluation of the translational potential of blood-based biomarkers, emphasizing their practical utility in clinical settings and offering insights into future directions for large-scale application. This review emphasizes the need to prioritize the allocation of scientific resources, expedite the transition of blood-based biomarkers to clinical implementation, and ultimately achieve precise treatment of Alzheimer’s disease using these biomarkers.

28 July 2025 in Neurochemical Research
Verified
Journal Article
Closed access
QYQian Yu
Qian Yu
LLLi Li
Li Li
SYShuyi Yu
Shuyi Yu
JHJialin Han
Jialin Han
QCQian Cheng
Qian Cheng
ZLZhiming Lu
Zhiming Lu

22 May 2023 in Cerebral Cortex
Verified
Journal Article
Closed access
PDF file
MLMing Li
Ming Li
JZJing Zhang
Jing Zhang
YSYuxuan Shi
Yuxuan Shi
SLShuang Liu
Shuang Liu
XLXin Liu
Xin Liu
YZYueran Zhao
Yueran Zhao
Menopause may be an important pathogenic factor for Alzheimer's disease (AD). The M1 polarization of microglia and neuroinflammatory responses occur in the early pathogenetic stages of AD. Currently, no effective monitoring markers are available for AD’s early pathological manifestations. Radiomics is an automated feature generation method for the extraction of hundreds of quantitative phenotypes (radiomics features) from radiology images. In this study, we retrospectively analyzed the magnetic resonance T2-weighted imaging (MR-T2WI) on the temporal lobe region and clinical data of both premenopausal and postmenopausal women. There were three significant differences were identified for select radiomic features in the temporal lobe between premenopausal and postmenopausal women, i.e. the texture feature Original-glcm-Idn (OI) based on the Original image, the filter-based first-order feature Log-firstorder-Mean (LM), and the texture feature Wavelet-LHH-glrlm-Run Length Nonuniformity (WLR). In humans, these three features were significantly correlated with the timing of menopause. In mice, these features were also different between the sham and ovariectomy (OVX) groups and were significantly associated with neuronal damage, microglial M1 polarization, neuroinflammation, and cognitive decline in the OVX groups. In AD patients, OI was significantly associated with cognitive decline, while LM was associated with anxiety and depression. OI and WLR could distinguish AD from healthy controls. In conclusion, radiomics features based on brain MR-T2WI scans have the potential to serve as biomarkers for AD and noninvasive monitoring of pathological progression in the temporal lobe of the brain in women undergoing menopause.